Persistent antigen exposure via the eryptotic pathway drives terminal T cell dysfunction

Area of Science:

• Immunology
• Cell Biology

Background:

• Current autoimmunity treatments rely on broad immunosuppression, increasing infection risks.
• Antigen-specific T cell suppression is a safer therapeutic goal.
• Targeting antigens to the apoptotic pathway can induce immune tolerance.

Purpose of the Study:

• To develop a method for inducing antigen-specific T cell dysfunction using erythrocytes.
• To investigate the mechanisms of T cell tolerance induced by antigen-associated eryptotic erythrocytes.

Main Methods:

• Antigens were bound to erythrocytes to induce eryptosis and subsequent uptake by antigen-presenting cells.
• Transcriptomic and phenotypic analyses were performed on T cells.
• The strategy was tested in a mouse model of experimental autoimmune encephalomyelitis (EAE).

Main Results:

• Erythrocyte-bound antigens induced sustained T cell dysfunction and exhaustion signatures (PD-1, CTLA4, Lag3, TOX).
• Antigen-specific T cells remained unresponsive to challenges long after antigen clearance.
• The approach prevented pathology in a mouse model of EAE, mediated by splenic Batf3+ dendritic cells.

Conclusions:

• Antigens presented via eryptotic erythrocytes induce lasting T cell dysfunction.
• This strategy holds promise for deactivating pathogenic T cells in autoimmune diseases.
• Further research could lead to safer, targeted therapies for autoimmunity.